UTHR

United Therapeutics Corporation (UTHR)

US
$ 301.42-2.14%

Price Chart

Key Statistics

Market Cap
$ 13.28B
P/E Ratio
11.74
Revenue (TTM)
$ 2.99B
Volume
331.89K
52W High
$ 417.81
52W Low
$ 266.98
Dividend Yield
0.00%
Beta
0.57

Technicals

50-Day MA
300.9776
200-Day MA
337.1256
52 Week High
417.815
52 Week Low
266.98

About UTHR

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening .

Employees
1305
Headquarters
Silver Spring, MD
CEO
Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D.

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score
35.51
Percentile: 53.55
Environmental Risk Score
6.16
Percentile: 9
Social Risk Score
24.94
Percentile: 9
Governance Risk Score
17.41
Percentile: 9

Controversy Level

ESG data provided by Sustainalytics, Inc.

UTHR
Category Average
2Moderate Controversy Level
NoneSevere

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg